SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.04X leverage
Performance
- Low
- ₹773
- High
- ₹808
- 52 Week Low
- ₹440
- 52 Week High
- ₹877
- Open Price₹777
- Previous Close₹784
- Volume134,372
- 50 DMA₹802.86
- 100 DMA₹775.99
- 200 DMA₹709.41
Investment Returns
- Over 1 Month -1.16%
- Over 3 Month + 1.72%
- Over 6 Month + 17.56%
- Over 1 Year + 54.14%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,656
- P/B Ratio
- 4.5
- Average True Range
- 29.42
- EPS
- 22.06
- Dividend Yield
- 0
- MACD Signal
- 0.34
- RSI
- 45.5
- MFI
- 55.85
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹793.80
+
10.25
(1.31%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹807.84
- 50 Day
- ₹802.86
- 100 Day
- ₹775.99
- 200 Day
- ₹709.41
Resistance and Support
791.45
- R3 845.65
- R2 826.80
- R1 810.30
- S1 774.95
- S2 756.10
- S3 739.60
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹793 As on 17 February, 2026 | 00:30
The Market Cap of Senores Pharmaceuticals is ₹3655.7 Cr As on 17 February, 2026 | 00:30
The P/E ratio of Senores Pharmaceuticals is 36 As on 17 February, 2026 | 00:30
The PB ratio of Senores Pharmaceuticals is 4.5 As on 17 February, 2026 | 00:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.